ArticlePostepy dermatologii i alergologii2019

Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic.

Olga Růžičková Kirchnerová et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.